Results 231 to 240 of about 1,696,934 (300)
Immunological Challenges and Emerging Strategies in Dengue Virus Vaccine Development. [PDF]
Ma X +6 more
europepmc +1 more source
Establishment of Humanized EFNB2/B3 Murine Models for Investigating Nipah Virus Pathogenesis
ABSTRACT Nipah virus (NiV) is a zoonotic paramyxovirus classified as a WHO priority pathogen, which causes severe respiratory disease and encephalitis in humans with high mortality. Currently, no licensed vaccines or specific antiviral therapies are available.
Wei Dong +6 more
wiley +1 more source
Engineering Biology Beyond Single Genes: Advances and Challenges in Multiplex Genome Editing
Multiplex genome editing is transforming genome engineering from single‐gene perturbation to network‐level control, yet its broader application remains limited by challenges in gRNA array engineering, delivery technologies, and safety management. Emerging AI‐driven approaches are accelerating guide RNA design and CRISPR effector optimization for ...
Linli Wang, Yongbin Liu, Hongbing Han
wiley +1 more source
Adverse Events Following Varicella-Containing Vaccination in Healthy Children: A Systematic Review and Meta-Analysis. [PDF]
Hu H, Jiaerken Y, Wang C, Fang H.
europepmc +1 more source
Objective To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. Methods We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA ...
Outi Sareila +12 more
wiley +1 more source
Review on anticoccidial vaccine development for chickens: Past progress, modern methods, and production bottlenecks. [PDF]
Yismaw M, Terefe G.
europepmc +1 more source
Objective Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post–acute COVID‐19 outcomes, though whether individuals with SARDs have longer persistence of viral antigens after COVID‐19 has not been studied.
Naomi J. Patel +18 more
wiley +1 more source
Advances in Bluetongue Virus Antigenicity and Vaccine Strategies: Progress and Perspectives. [PDF]
Li X, Ye Z, Lei N, Pu S, Yi H, Ma X.
europepmc +1 more source
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner +52 more
wiley +1 more source
Trained Immunity in Childhood Vaccination. [PDF]
Cai C, Hossenbaccus L, Kaufmann E.
europepmc +1 more source

